Rising Amyotrophic Lateral Sclerosis (ALS) Market and Diagnostic Demand Fuel Global Market Expansion and Drug Pipelines 2025-2033 | Japan Technology

The global Amyotrophic Lateral Sclerosis (ALS) Market reached US$ 0.82 billion in 2024 and is expected to reach US$ 1.22 billion by 2033, growing at a CAGR of 5.1 % during the forecast period of 2025-2033.

Japanese Researchers Launch AI-Powered Platform to Accelerate ALS Drug Discovery

In May 2025, researchers from Kyoto University partnered with several biotech firms to launch a cutting-edge AI-based platform to identify and validate potential ALS drug targets. This initiative, supported by Japan's Ministry of Health, aims to reduce drug development timelines and increase treatment accessibility for ALS patients in Japan and globally.

Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/amyotrophic-lateral-sclerosis-market?kb

Amyotrophic Lateral Sclerosis Market Overview

The Amyotrophic Lateral Sclerosis (ALS) Market refers to the industry focused on the research, development, and commercialization of treatments and diagnostics for ALS, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually respiratory failure.

Research Methodology:

The global Amyotrophic Lateral Sclerosis Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.

Segment Covered in the Amyotrophic Lateral Sclerosis Market:

By Drug: Rilutek (Riluzole), Edaravone (Radicava), Others

By Treatment Type: Physical therapy, Speech Therapy, Medication, Respiratory Therapy, Others

By End-User: Diagnostic Centers, Hospitals, Clinics, Others

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/amyotrophic-lateral-sclerosis-market?kb

List of the Key Players in the Amyotrophic Lateral Sclerosis Market:

BIOGEN, Sanofi, Otsuka Holdings Co., Ltd., Mitsubishi Tanabe Pharma, EDW Pharma, Inc., BrainStorm Cell Therapeutics, Eisai Co., Ltd., Rappta Therapeutics, AB Science, and CorestemChemon Inc., among others.

Industry Development:

In September 2024, Eisai Co., Ltd. received marketing authorization in Japan for Rozebalamin (Mecobalamin), approved for the treatment of amyotrophic lateral sclerosis (ALS).

Earlier, in August 2023, the U.S. FDA granted accelerated approval for tofersen (brand name QALSODY), a treatment for ALS in adults with a mutation in the SOD1 gene. Developed by Biogen Inc., QALSODY is the first gene-targeted ALS therapy, available as a 100 mg/15 mL injection.

Regional Analysis for Amyotrophic Lateral Sclerosis Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Go-to-market Strategy.

➡ Neutral perspective on the market performance.

➡ Customized regional/country reports as per request and country level analysis.

➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Amyotrophic Lateral Sclerosis market?

➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?

➠ What key opportunities and challenges do vendors face in the Amyotrophic Lateral Sclerosis industry?

➠ Which product types, applications, or end-users are driving market growth, and what is their market share?

➠ What are the major growth drivers and restraints of the Amyotrophic Lateral Sclerosis market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.